Most Recent
Australia's leading livestock group cannot block US company Branhaven from amending its application for a bovine genome patent, which the group has worried could harm the Australian cattle industry's ability to use genetic tests.
Five investment banks facing a class action for their alleged rigging of foreign exchange rates have slammed the "unclear" and "incredibly vague" case, saying it contains "literally trillions" of possible variations of the cartel agreement allegedly entered into.
McMillan Shakespeare has settled a class action alleging one of its units engaged in unfair tactics and unconscionable conduct in the sale of car warranties that offered "no benefit or value" to consumers.
Isuzu plans to lodge cross-claims against electronics company Directed Electronics and various third parties in an $18 million lawsuit accusing the commercial vehicle manufacturer of contract and copyright breaches and aiding a former employee's alleged theft of company information.
Mining giant Glencore has won its appeal over access charges to Port of Newcastle shipping channels used to export coal from the Hunter Valley.
The Commonwealth Bank of Australia has been hit with another class action for allegedly pushing insurance policies with excessive premiums onto customers.
The legal watchdog in Victoria will be asked to probe potential misconduct against the legal team behind the controversial Banksia Securities class action for their fees in a separate class action, which last year settled for $40 million.
Australian auto electronics company Directed Electronics is seeking at least $18 million from truck company Isuzu for allegedly breaching a contract for the supply of a new audio visual unit and aiding a former employee's alleged theft of company information.
An appeals court has been urged to uphold a judge's $125 million penalty against Volkswagen in the ACCC's case over the car maker's emissions cheating, with a court-appointed contradictor saying the judge was "starved" of the information he required to assess whether a $75 million agreement brokered by the consumer watchdog was reasonable.
Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling antidepressant Lexapro.